Your browser is no longer supported. Please, upgrade your browser.
Settings
SNTA Synta Pharmaceuticals Corp. daily Stock Chart
SNTA [NASD]
Synta Pharmaceuticals Corp.
Index- P/E- EPS (ttm)-0.80 Insider Own3.30% Shs Outstand134.43M Perf Week-11.65%
Market Cap295.75M Forward P/E- EPS next Y-0.67 Insider Trans163.59% Shs Float86.29M Perf Month-0.90%
Income-83.30M PEG- EPS next Q-0.18 Inst Own27.30% Short Float9.69% Perf Quarter10.55%
Sales- P/S- EPS this Y31.50% Inst Trans44.45% Short Ratio5.50 Perf Half Y-15.38%
Book/sh0.43 P/B5.12 EPS next Y9.50% ROA-79.50% Target Price8.80 Perf Year-46.34%
Cash/sh0.57 P/C3.86 EPS next 5Y0.00% ROE-124.10% 52W Range1.85 - 4.97 Perf YTD-16.98%
Dividend- P/FCF- EPS past 5Y-18.90% ROI- 52W High-55.73% Beta2.40
Dividend %- Quick Ratio2.50 Sales past 5Y- Gross Margin- 52W Low18.92% ATR0.13
Employees110 Current Ratio2.50 Sales Q/Q- Oper. Margin- RSI (14)39.41 Volatility6.58% 5.78%
OptionableYes Debt/Eq0.25 EPS Q/Q32.10% Profit Margin- Rel Volume0.63 Prev Close2.23
ShortableYes LT Debt/Eq0.05 EarningsAug 05 BMO Payout- Avg Volume1.52M Price2.20
Recom2.00 SMA20-8.20% SMA50-7.66% SMA200-17.15% Volume1,078,300 Change-1.35%
Apr-27-15Reiterated ROTH Capital Buy $20 → $13
Feb-06-15Reiterated ROTH Capital Buy $27 → $20
Mar-13-14Reiterated MLV & Co Buy $10 → $6
Mar-12-14Downgrade Stifel Hold → Sell
Nov-05-13Reiterated MLV & Co Buy $16 → $10
Jun-06-13Reiterated MLV & Co Buy $18.50 → $16
Apr-01-13Reiterated MLV & Co Buy $16 → $18.50
Aug-30-12Initiated Stifel Nicolaus Hold
Jan-05-12Initiated Rodman & Renshaw Mkt Outperform $8
Mar-14-11Reiterated Barclays Capital Equal Weight $2 → $4
Feb-28-11Upgrade Canaccord Genuity Hold → Buy $4.50 → $8
Nov-09-10Initiated MLV Capital Buy $8.50
Aug-26-10Initiated Morgan Joseph Buy $6
May-10-10Upgrade Roth Capital Hold → Buy $4
Feb-19-10Initiated RBC Capital Mkts Sector Perform $5
Feb-17-10Downgrade Roth Capital Buy → Hold $4
Nov-05-09Upgrade Roth Capital Hold → Buy $2 → $4
Feb-27-09Downgrade Wachovia Mkt Perform → Underperform
Feb-27-09Downgrade Roth Capital Buy → Hold $11 → $2
Feb-27-09Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
Jun-24-15 03:35PM  Synta Reports Encouraging Preclinical Data on Ganetespib - Analyst Blog
Jun-23-15 08:00AM  Synta Announces Journal Publication Describing Complementary Activity of Hsp90 Inhibition and Immune Checkpoint Blockade for Cancer Therapy Business Wire
Jun-16-15 04:01PM  Synta to Participate in Upcoming Investor Conferences Business Wire
Jun-15-15 07:59AM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a
Jun-02-15 09:00AM  Synta Announces Ganetespib Program Updates Business Wire
May-28-15 04:30PM  Synta Announces Presentations at the 2015 ASCO Annual Meeting Business Wire
May-27-15 04:01PM  Synta to Present at the Jefferies 2015 Global Healthcare Conference Business Wire
May-15-15 01:04PM  SYNTA PHARMACEUTICALS CORP Financials
May-11-15 12:10PM  On the move: New hires and appointments in the local life sciences industry at bizjournals.com
May-10-15 08:11PM  10-Q for Synta Pharmaceuticals Corp. at Company Spotlight
May-07-15 10:00AM  Synta Pharmaceuticals Corp Earnings Call scheduled for 10:00 am ET today
08:27AM  Synta Reports First Quarter 2015 Financial Results at noodls
08:13AM  Synta reports 1Q loss
07:57AM  Synta's (SNTA) Q1 Loss In Line with Expectations - Tale of the Tape
07:07AM  Q1 2015 Synta Pharmaceuticals Corp Earnings Release - Before Market Open
07:00AM  Synta Reports First Quarter 2015 Financial Results Business Wire
06:22AM  SYNTA PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report
May-06-15 08:12PM  10-K for Synta Pharmaceuticals Corp. at Company Spotlight
May-05-15 04:00PM  Will Synta (SNTA) Disappoint this Earnings Season? - Analyst Blog
Apr-30-15 04:57PM  Synta to Host Conference Call and Webcast of First Quarter 2015 Financial Results on May 7, 2015 at noodls -5.46%
04:01PM  Synta to Host Conference Call and Webcast of First Quarter 2015 Financial Results on May 7, 2015 Business Wire
Apr-28-15 06:15AM  Five things you need to know today, including Twitter Boston hiring, tech jobs and Coffee Trike guy's new espresso bar at bizjournals.com
Apr-27-15 10:17AM  Synta Pharmaceuticals names third CEO since March 2014 at bizjournals.com -9.67%
07:39AM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex
07:36AM  Synta Announces Chen Schor Named President, Chief Executive Officer and Director at noodls
07:30AM  Synta Announces Chen Schor Named President, Chief Executive Officer and Director Business Wire
Apr-16-15 01:35PM  A surge in interest in Synta's cancer drug ahead of key science data at bizjournals.com
12:01PM  Synta Pharmaceuticals (SNTA) Stock Rises Today After Announcing Upcoming Presentations at TheStreet
08:44AM  Synta Pharmaceuticals (SNTA) Catches Eye: Stock Jumps 10.7% - Tale of the Tape
08:28AM  Synta Announces Presentations at the 2015 Annual Meeting of the American Association of Cancer Research at noodls
08:00AM  Synta Announces Presentations at the 2015 Annual Meeting of the American Association of Cancer Research Business Wire
Apr-06-15 05:23PM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits +6.06%
12:01PM  Synta Pharmaceuticals Closes Public Offering of Common Stock at noodls
11:30AM  Synta Pharmaceuticals Closes Public Offering of Common Stock Business Wire
Apr-01-15 06:08AM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial St
Mar-31-15 10:04AM  Synta Pharmaceuticals (SNTA) Stock Hits 52-Week Low After Pricing Public Offering at TheStreet -16.74%
09:27AM  Synta Pharmaceuticals Prices Public Offering of Common Stock at noodls
09:15AM  Synta Pharmaceuticals Prices Public Offering of Common Stock Business Wire
Mar-30-15 04:19PM  Synta Pharmaceuticals Announces Proposed Public Offering of Common Stock at noodls
04:01PM  Synta Pharmaceuticals Announces Proposed Public Offering of Common Stock Business Wire
Mar-13-15 10:14AM  Synta's Q4 Loss Narrows Y/Y, Focus on Lung Cancer Drug - Analyst Blog
Mar-12-15 08:30AM  Synta Pharmaceuticals Corp Earnings Call scheduled for 8:30 am ET today
08:25AM  Synta's (SNTA) Q4 Loss In Line with Expectations - Tale of the Tape
07:30AM  Synta reports 4Q loss
07:25AM  Synta Reports Fourth Quarter and Year-End 2014 Financial Results at noodls
07:07AM  Q4 2014 Synta Pharmaceuticals Corp. Earnings Release - Before Market Open
07:00AM  Synta Reports Fourth Quarter and Year-End 2014 Financial Results Business Wire
06:12AM  SYNTA PHARMACEUTICALS CORP Files SEC form 10-K, Annual Report
Mar-11-15 10:30AM  What Awaits Synta Pharmaceuticals (SNTA) this Earnings? - Analyst Blog
Mar-10-15 03:05PM  Synta to Host Conference Call and Webcast of Fourth Quarter and Year-End 2014 Financial Results on March 12, 2015 at noodls
Mar-06-15 07:15AM  Will Synta Pharmaceuticals (SNTA) Continue to Surge Higher? - Tale of the Tape -5.24%
Mar-05-15 09:56AM  5 Stocks Under $10 Set to Soar: Breakout Stocks at TheStreet +9.88%
Feb-27-15 03:48PM  Synta to Present at Upcoming Conferences at noodls
Feb-26-15 04:01PM  Synta to Host Conference Call and Webcast of Fourth Quarter and Year-End 2014 Financial Results on March 12, 2015 Business Wire
Feb-25-15 04:01PM  Synta to Present at Upcoming Conferences Business Wire
Feb-06-15 10:25AM  Lexington-based Synta to cut 20 percent of workforce and consolidate lab space at bizjournals.com
Feb-05-15 05:23PM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +5.33%
04:01PM  Synta Outlines New Corporate Strategy Business Wire
Feb-03-15 04:01PM  Synta to Present at the 17th Annual BIO CEO & Investor Conference Business Wire
Dec-12-14 08:00AM  Synta Announces Presentation of Results from an Investigator-Sponsored Phase 1 Trial of Ganetespib in HER2+ Metastatic Breast Cancer at the 2014 San Antonio Breast Cancer Symposium Business Wire
Dec-10-14 04:30PM  Synta Reports Inducement Grants to New Chief Operating Officer and New Chief Financial Officer Business Wire
Dec-04-14 05:06PM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex EDGAR Online
04:30PM  Synta Strengthens Management Team with Two Executive Appointments Business Wire
Nov-19-14 07:00AM  Synta Announces Presentation on Hsp90 inhibitor Drug Conjugate Platform at 26th EORTC-NCI-AACR Symposium Business Wire
Nov-12-14 04:01PM  Synta to Present at the Stifel 2014 Healthcare Conference Business Wire
Nov-09-14 07:09PM  10-Q for Synta Pharmaceuticals Corp. Company Spotlight
Nov-06-14 10:00AM  Synta Pharmaceuticals Corp Earnings Call scheduled for 10:00 am ET today CCBN
08:52AM  Synta beats 3Q profit forecasts AP
07:07AM  Q3 2014 Synta Pharmaceuticals Corp Earnings Release - Before Market Open CCBN
07:00AM  Synta Reports Third Quarter Financial Results and Provides Corporate Update Business Wire
06:08AM  SYNTA PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-05-14 04:00PM  Will Synta Pharmaceuticals (SNTA) Post a Wider Q3 Loss? Zacks
08:00AM  Synta Announces FDAs Oncologic Drugs Advisory Committee to Discuss Pediatric Uses for Ganetespib Business Wire
Oct-29-14 07:00AM  Synta Announces Initiation of I-SPY 2 TRIAL of Ganetespib in Breast Cancer Business Wire
Oct-27-14 04:01PM  Synta to Host Conference Call and Webcast of Third Quarter 2014 Financial Results on November 6, 2014 Business Wire
Sep-04-14 04:30PM  Synta Reports Inducement Grant to New Chief Executive Officer Business Wire
Aug-06-14 04:23PM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex EDGAR Online
10:00AM  Synta Pharmaceuticals Corp Earnings Call scheduled for 10:00 am ET today CCBN
07:07AM  Q2 2014 Synta Pharmaceuticals Corp Earnings Release - Before Market Open CCBN
07:01AM  Synta Names Anne Whitaker Chief Executive Officer Business Wire
07:00AM  Synta Reports Second Quarter Financial Results and Provides Corporate Update Business Wire
06:05AM  SYNTA PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
Jul-30-14 08:00AM  Synta to Host Conference Call and Webcast of Second Quarter 2014 Financial Results on August 6, 2014 Business Wire
Jul-22-14 09:07AM  Synta Pharmaceuticals data positive, says JMP Securities at theflyonthewall.com
Jul-21-14 05:07PM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:30PM  Synta Announces Advancement of Ganetespib into Phase 3 Extension of AML LI-1 Study for Patients with AML and High-Risk MDS Business Wire
Jul-18-14 04:16PM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material EDGAR Online
Jul-08-14 06:54AM  Synta Pharmaceuticals (SNTA) Shares March Higher, Can It Continue? Zacks
Jul-07-14 06:40AM  Synta Pharmaceuticals (SNTA) Jumps: Stock Rises 7.9% Zacks +5.33%
Jun-27-14 04:23PM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Jun-24-14 02:31PM  Synta Pharmaceuticals mentioned positively by The Street contributor at theflyonthewall.com -5.16%
02:22PM  A Beaten-Down Biotech Stock Gearing Up for a Big Squeeze Higher at TheStreet
Jun-19-14 04:01PM  Synta to Present at the 9th Annual JMP Securities Healthcare Conference Business Wire
Jun-18-14 03:26PM  5-Star Biotech Stock Watch: Synta Pharmaceuticals Benzinga
Jun-17-14 04:14PM  SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Jun-16-14 02:27PM  3 Biotech Stocks Backed By Big Money Benzinga
10:00AM  Why A Short Covering Rally Might Come for Synta (SNTA) Stock Zacks
08:47AM  Five Biotech Stocks With Big Potential And Billionaire Believers at Forbes
May-29-14 08:00AM  Synta to Present at the Jefferies 2014 Global Healthcare Conference Business Wire
May-28-14 08:00AM  Synta Announces Presentations at the 2014 American Society for Clinical Oncology (ASCO) Annual Meeting Business Wire
Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. Its lead oncology drug candidate includes ganetespib, an Hsp90 inhibitor, which is in Phase III clinical trial for the treatment of non-small cell lung cancer; in Phase II clinical trial for patients with hormone receptor positive metastatic breast cancer; in Phase I clinical trial for the treatment of HER2 positive patients with metastatic breast cancer; in Phase II/III clinical trial for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome; in Phase I/II trial of paclitaxel in combination with ganetespib in patients with platinum-resistant ovarian cancer; and in Phase I/II trial in combination with the mTOR inhibitor sirolimus in patients with refractory sarcoma. The company's product pipeline also comprises Hsp90-inhibitor Drug Conjugate, a novel, proprietary small molecule cancer drug development program; Elesclomol, a mitochondria-targeting agent that is in Phase II clinical trial for ovarian cancer; and CRACM ion channel inhibitors and IL-12/23 inhibitors for the treatment of inflammatory diseases. Synta Pharmaceuticals Corp. was incorporated in 2000 and is based in Lexington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kovner BruceDirectorApr 06Buy1.756,857,14312,000,00015,278,610Apr 08 04:21 PM
Gollust Keith RDirectorApr 06Buy1.75350,000612,5003,173,383Apr 08 04:18 PM
WILSON ROBERT NDirectorApr 06Buy1.7550,00087,500754,118Apr 08 04:16 PM
Kovner BruceDirectorSep 30Buy3.08300,000923,1308,421,467Oct 01 01:56 PM